Dompé Farmaceutici S.p.a

This study tests an eye drop containing a human nerve growth factor (cenegermin) to see if it can heal persistent corneal epithelial defects — stubborn wounds on the clear front part of the eye that haven't healed with standard treatments. About 150 adults with such wounds will r…

This study tests a nasal spray called cenegermin (a lab-made nerve growth factor) to see if it can improve vision in people who recently lost sight due to a condition called NAION, which is like a stroke of the optic nerve. About 272 adults who had vision loss within the past two…

This study tests a new eye drop called DFL24498 in about 417 adults with dry eye disease. The drops are meant to reduce eye dryness and damage to the eye's surface. Participants will use the drops twice a day for 12 weeks, and doctors will check if their symptoms and eye health i…